Baxdrostat: A “Game Changer” for Hypertension?

Use of baxdrostat was associated with a reduction in office-measured systolic blood pressure of around 9 mm Hg at 12 weeks and reductions in 24-hour ambulatory systolic blood pressure of around 15 mm Hg in the BaxHTN trial. 

Подробнее